Edasalonexent, an NF-kappa B Inhibitor, slows disease progression over more than a year compared to control period in 4 to 7 year old patients with Duchenne muscular dystrophy

NEUROMUSCULAR DISORDERS(2018)

Cited 0|Views7
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined